These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1731036)

  • 1. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation.
    Ayesta FJ; Ableitner A; Emmett-Oglesby MW; Herz A; Shippenberg TS
    J Pharmacol Exp Ther; 1992 Jan; 260(1):168-74. PubMed ID: 1731036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.
    Adams JU; Holtzman SG
    J Pharmacol Exp Ther; 1990 May; 253(2):483-9. PubMed ID: 2338644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
    France CP; Gerak LR; Flynn D; Winger GD; Medzihradsky F; Bagley JR; Brockunier LL; Woods JH
    J Pharmacol Exp Ther; 1995 Jul; 274(1):17-28. PubMed ID: 7616395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1988 Feb; 244(2):599-605. PubMed ID: 3346837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.
    Tempel A; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):439-44. PubMed ID: 2982011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
    Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
    Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
    Koek W; Colpaert FC; Vignon J
    J Pharmacol Exp Ther; 1993 Feb; 264(2):746-56. PubMed ID: 8437123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone.
    Gerrits MA; Kuzmin AV; van Ree JM
    Eur Neuropsychopharmacol; 2005 May; 15(3):297-303. PubMed ID: 15820419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):195-202. PubMed ID: 3612524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1989 Sep; 250(3):937-43. PubMed ID: 2550623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.